Roche mixes Actemra with Gilead's remdesivir in Covid-19 trial
May 28, 2020 at 02:45 AM EDT
Roche is hoping that by combining the two in a global study of 450 hospitalized patients worldwide, it will be able to offer doctors a one-two punch against the disease.